Tag:
Excelimmune
Latest Headlines
Latest Headlines
Biotech upstart raises $10.5M for MRSA antibody
Hoping to thrive in a development arena long neglected by Big Pharma, Woburn, MA-based Excelimmune has raised $10.5 million in a Series B to fund its work on an antibody candidate targeting MRSA. The
Excelimmune garners $4.5M in new financing
Woburn, MA-based Excelimmune has rounded up $4.5 million in new financing for its planned clinical development work on polyclonal antibodies. The financing--roughly half of the $8.9 million the
